Abiopharma

🔍 Parker Ava L (Director)

Company: MASTEC INC (MTZ)

Report Date: 2026-08-14

Detailed Transactions and Holdings:

• Acquired 177 shares of Common Stock (Direct)
  Date: 2026-08-14 | Code: A | equity_swap_involved: 0 | shares_owned_after: 5,569.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 20 shares of Common Stock at $297.59 per share (Direct)
  Date: 2026-08-14 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,549.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: These shares of Common Stock represent the portion of the reporting person's quarterly compensation that the reporting person was required to or elected to receive in the form of shares of Common Stock. The number of shares was calculated based on the closing price of a share of Common Stock on August 14, 2026. Pursuant to the Issuer's Deferred Fee Plan for Directors, the reporting person elected to defer the receipt of 88 of such shares to a future date in accordance with the terms of such plan.
• F2: Shares disposed of represent shares withheld by the Issuer to pay taxes due upon vesting of restricted stock.